Brexit

UK medicines regulator seeks to allay pharma industry concern, reiterating a previous promise it will be pragmatic in setting new UK drugs rules in event of no-deal Brexit

Research spending should rise to €120B in the 2021 - 2028 budget, despite shrinking EU funds post-Brexit, say MEPs

A Scottish government report lays out potential hit of divorce in a new economic forecast that first minister Nicola Sturgeon says strengthens case for UK remaining in EU single market

Viewpoint: More EU ministers and commissioners are voicing support for bigger research and innovation funding – but the political argument is a long way from won

Sector deal features 25 investments from global companies and a pledge by government to provide funding for research infrastructure and long-term capital to allow start-ups to scale

There is more than a hint of dirigisme in the first explicit national industrial strategy since the 1970s. The government says it is not about picking winners, but shaping the environment as a whole

Agency bracing itself for a potential exodus, while pharma companies fear a bottleneck in new drug approvals. Meanwhile, the bill for the removal stands at €400M

City pips Milan in tiebreaker to scoop hotly sought-after prize from London

Institutions from 22 countries demand clarification on whether and how UK will be able to participate in future EU research projects